Bio-IT World July 16, 2024
Deborah Borfitz

Artificial intelligence (AI) is the new frontier in biomedical research, with large language models changing the way science is done from writing code and brainstorming research ideas to helping do research and conducting literature reviews. In some of its latest applications, generative AI has been used in designing molecules with insights produced at a scale and speed not possible with traditional deep learning methods alone, according to Marinka Zitnik, Ph.D., assistant professor of biomedical informatics at Harvard Medical School.

The potential of AI to aid in the development of new drugs to cure disease is enormous given the size of the chemical universe (1060 chemical compounds) relative to the tiny fraction (105) that has been synthesized...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Biotechnology, Partnerships, Pharma / Biotech, Technology, Trends
CZI’s Priscilla Chan on ‘Virtual Cells’ AI Models to Cure Diseases
Ensitrelvir Shows Promise Preventing COVID-19 Post Exposure
Gene Therapy Biotech MeiraGTx Strikes Deal Bringing Generative AI to Pivotal Parkinson’s Trial
Pharma Pulse 3/14/25: Navigating Internal Constraints and Uncertainty, Health Plan Support During Natural Disasters & more
New AI model can estimate a person's true biological age from five drops of blood

Share This Article